Photo by Victor Freitas on Unsplash
Startups pioneering less-invasive technologies to treat common eye diseases are changing the outlook for both patients and the industry.
A new study by CB Insights revealed that investors have been pouring money into smaller companies in 2017 and 2018, with some FDA approvals to begin marketing their technologies and treatments. These firms are eyeing conditions common among those age 40+, including refractive errors (e.g. near- or farsightedness), cataracts, and retinal diseases like diabetic retinopathy and macular degeneration.
Get the full story on our sister site, Medical Design & Outsourcing.
The post New eye health companies gain funders’ focus appeared first on MassDevice.
from MassDevice https://ift.tt/2P1Y4c2
Cap comentari:
Publica un comentari a l'entrada